These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 34383742)

  • 1. Livestock herding and Fulani ethnicity are a combined risk factor for development of early adverse reactions to antivenom treatment: Findings from a cross-sectional study in Nigeria.
    Menzies SK; Thomas AO; Tianyi FL; Abubakar SB; Nasidi A; Durfa N; Patel R; Trelfa A; Lalloo DG; Habib AG; Harrison RA
    PLoS Negl Trop Dis; 2021 Aug; 15(8):e0009518. PubMed ID: 34383742
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antivenom use, premedication and early adverse reactions in the management of snake bites in rural Papua New Guinea.
    Williams DJ; Jensen SD; Nimorakiotakis B; Müller R; Winkel KD
    Toxicon; 2007 May; 49(6):780-92. PubMed ID: 17210167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose of antivenom for the treatment of snakebite with neurotoxic envenoming: Evidence from a randomised controlled trial in Nepal.
    Alirol E; Sharma SK; Ghimire A; Poncet A; Combescure C; Thapa C; Paudel VP; Adhikary K; Taylor WR; Warrell D; Kuch U; Chappuis F
    PLoS Negl Trop Dis; 2017 May; 11(5):e0005612. PubMed ID: 28510574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence of serum sickness following Indian polyvalent antivenom therapy in a cohort of snake-envenomed patients in rural Sri Lanka.
    Waiddyanatha S; Silva A; Wedasingha S; Siribaddana S; Isbister GK
    Clin Toxicol (Phila); 2023 Jul; 61(7):518-523. PubMed ID: 37486099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Allergic Reactions Following Intravenous Infusion of Polyvalent Antivenom in Snakebite Patients.
    Mahmoudi GA; Ahadi M; Fouladvand A; Rezaei B; Bodagh Z; Astaraki P
    Antiinflamm Antiallergy Agents Med Chem; 2021; 20(4):367-372. PubMed ID: 33563188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose adrenaline, promethazine, and hydrocortisone in the prevention of acute adverse reactions to antivenom following snakebite: a randomised, double-blind, placebo-controlled trial.
    de Silva HA; Pathmeswaran A; Ranasinha CD; Jayamanne S; Samarakoon SB; Hittharage A; Kalupahana R; Ratnatilaka GA; Uluwatthage W; Aronson JK; Armitage JM; Lalloo DG; de Silva HJ
    PLoS Med; 2011 May; 8(5):e1000435. PubMed ID: 21572992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current use of Australian snake antivenoms and frequency of immediate-type hypersensitivity reactions and anaphylaxis.
    Isbister GK; Brown SG; MacDonald E; White J; Currie BJ;
    Med J Aust; 2008 Apr; 188(8):473-6. PubMed ID: 18429716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Australian Snakebite Project, 2005-2015 (ASP-20).
    Johnston CI; Ryan NM; Page CB; Buckley NA; Brown SG; O'Leary MA; Isbister GK
    Med J Aust; 2017 Aug; 207(3):119-125. PubMed ID: 28764620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of antivenoms for snakebite envenoming in Nigeria.
    Habib AG; Lamorde M; Dalhat MM; Habib ZG; Kuznik A
    PLoS Negl Trop Dis; 2015 Jan; 9(1):e3381. PubMed ID: 25569252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mulga snake (Pseudechis australis) envenoming: a spectrum of myotoxicity, anticoagulant coagulopathy, haemolysis and the role of early antivenom therapy - Australian Snakebite Project (ASP-19).
    Johnston CI; Brown SG; O'Leary MA; Currie BJ; Greenberg R; Taylor M; Barnes C; White J; Isbister GK;
    Clin Toxicol (Phila); 2013 Jun; 51(5):417-24. PubMed ID: 23586640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of intravenous hydrocortisone administered 2-4 h prior to antivenom as prophylaxis against adverse drug reactions to snake antivenom in Sri Lanka: An open labelled randomized controlled trial.
    Kularatne SA; Weerakoon K; Silva A; Maduwage K; Walathara C; Rathnayake I; Medagedara S; Paranagama R; Mendis S; Kumarasiri PV
    Toxicon; 2016 Sep; 120():159-65. PubMed ID: 27530663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prospective, consecutive case series of 158 snakebite patients treated at Savannakhet provincial hospital, Lao People's Democratic Republic with high incidence of anaphylactic shock to horse derived F(ab')2 antivenom.
    Vongphoumy I; Chanthilat P; Vilayvong P; Blessmann J
    Toxicon; 2016 Jul; 117():13-21. PubMed ID: 26995210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous administration of equine-derived whole IgG antivenom does not induce early adverse reactions in non-envenomed horses and cows.
    Estrada R; Herrera M; Segura A; Araya J; Boschini C; Gutiérrez JM; León G
    Biologicals; 2010 Nov; 38(6):664-9. PubMed ID: 20833066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse Reactions after Administration of Antivenom in Korea.
    Shim JS; Kang H; Cho Y; Shin H; Lee H
    Toxins (Basel); 2020 Aug; 12(8):. PubMed ID: 32781766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical effects of red-bellied black snake (Pseudechis porphyriacus) envenoming and correlation with venom concentrations: Australian Snakebite Project (ASP-11).
    Churchman A; O'Leary MA; Buckley NA; Page CB; Tankel A; Gavaghan C; Holdgate A; Brown SG; Isbister GK
    Med J Aust; 2010 Dec 6-20; 193(11-12):696-700. PubMed ID: 21143062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bothrops asper envenoming in cattle: Clinical features and management using equine-derived whole IgG antivenom.
    Rodríguez C; Estrada R; Herrera M; Gómez A; Segura Á; Vargas M; Villalta M; León G
    Vet J; 2016 Jan; 207():160-3. PubMed ID: 27152384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immune response to snake envenoming and treatment with antivenom; complement activation, cytokine production and mast cell degranulation.
    Stone SF; Isbister GK; Shahmy S; Mohamed F; Abeysinghe C; Karunathilake H; Ariaratnam A; Jacoby-Alner TE; Cotterell CL; Brown SG
    PLoS Negl Trop Dis; 2013; 7(7):e2326. PubMed ID: 23936562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of hypersensitivity reactions to snake antivenoms administered in sultanah nur zahirah hospital from 2013 to 2016.
    Nur AS; Hamid F; Mohd Shahezwan AW; Mohd Zaki FS; Ahmad KI
    Med J Malaysia; 2020 May; 75(3):216-220. PubMed ID: 32467535
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of effectiveness of Iranian snake antivenom on Viper venom induced effects including analysis of immunologic biomarkers in the Echis carinatus sochureki envenomed victims.
    Monzavi SM; Afshari R; Khoshdel AR; Mahmoudi M; Salarian AA; Samieimanesh F; Shirmast E; Mihandoust A
    Toxicon; 2019 Feb; 158():38-46. PubMed ID: 30452924
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A retrospective study of antivenom-associated adverse reaction and anaphylaxis at Ngwelezana Hospital, South Africa.
    Giles T; Čačala SR; Wood D; Klopper J; Oosthuizen GV
    Toxicon; 2022 Oct; 217():1-4. PubMed ID: 35870542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.